For the Inventor, By the Inventor

Enter assignee name

Oxford, United Kingdom

British Bio-Technology Limited

USPTO Granted Patents = 25

Forward Citations = 272

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Mark Whittaker (8 out of 53 patents)

Alan H Davidson (8 out of 13 patents)

Andrew Miller (6 out of 32 patents)

4. Jonathan P Dickens (6 out of 12 patents)

5. Michael John Crimmin (5 out of 14 patents)

6. Stephen Arthur Bowles (4 out of 12 patents)

7. Richard Mark Edwards (3 out of 12 patents)

8. Colin Campion (3 out of 5 patents)

9. Keith Martyn Dawson (3 out of 8 patents)

10. Michael George Hunter (2 out of 17 patents)

11. Christopher Norman Lewis (2 out of 8 patents)

12. Christopher D Floyd (2 out of 2 patents)

13. R P Beckett (2 out of 2 patents)

14. A H Davidson (2 out of 2 patents)

15. M J Crimmin (2 out of 2 patents)

Core Competencies:

Insulin-like Growth Factor II

IGF-II Analogues

Thrombin Activatable Plasminogen

Cyclic Ether Acetal

Hydroxamic Acid

Collagenase Inhibitors

Fibrinolytic Dimer

Benzimidazole Derivatives

Spirocyclic PAF Antagonists

Imidazopyridinyl

Heterobicyclic Compounds

Gene Synthesis

25 patents: Sort by Forward Citations

1. 5807822 - Insulin-like growth factor II as a pharmaceutical agent in the treatment (1998-09-15),

2. 5736363 - IGF-II analogues (1998-04-07),

3. 5688664 - Thrombin activatable plasminogen analogues (1997-11-18),

4. 5637595 - Cyclic ether acetal PAF antagonists (1997-06-10),

5. 5530161 - Hydroxamic acid based collagenase inhibitors (1996-06-25),

6. 5525629 - Inhibition of cytokine production (1996-06-11),

7. 5434073 - Fibrinolytic and anti-thrombotic cleavable dimers (1995-07-18),

8. 5412145 - P2'-modified hydroxamic acid collagenase inhibitors (1995-05-02),

9. 5314880 - Benzimidazole derivatives (1994-05-24),

10. 5310763 - Hydroxamino acid based collagenase inhibitors (1994-05-10),

11. 5308864 - 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones (1994-05-03),

12. 5304604 - Hydroxamic acid collagenase inhibotors (1994-04-19),

13. 5300674 - P2'-modified hydroxamic acid collagenase inhibitors (1994-04-05),

14. 5300524 - Spirocyclic PAF antagonists (1994-04-05),

15. 5276153 - Production of certain imidazopyridinyl-methyl-benzene sulfonamides (1994-01-04),

Company Overview

British Bio-Technology Limited, based in Oxford, specializes in the development of innovative biopharmaceuticals. The company focuses on creating novel therapies for serious diseases, leveraging advanced biotechnology techniques. Its research spans various domains, including infectious diseases and oncology, aiming to address unmet medical needs through cutting-edge science. With a commitment to improving patient outcomes, British Bio-Technology collaborates with partners to bring transformative treatments to market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

25 Patents

#11 in Oxford

#702 in United Kingdom

#25,710 in the World

Oxford, United Kingdom

British Bio-Technology Limited

Forward Citations = 272

30 inventors:

Mark Whittaker (8 out of 53 patents)

Alan H Davidson (8 out of 13 patents)

Andrew Miller (6 out of 32 patents)

4. Jonathan P Dickens (6 out of 12 patents)

5. Michael John Crimmin (5 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: British Bio-Technology Limited. Retrieved from https://idiyas.com/company/british-bio-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…